roi
Bluelighter
- Joined
- Sep 2, 2013
- Messages
- 1,545
2-(3-methoxyphenyl)-2-(pyrrolidin-1-yl)cyclohexan-1-one
Has anyone tried this one yet?
Appeared at the same time as 2-Chloro-2-Oxo-PCPy.
Last edited:
N&PD Moderators: Skorpio | thegreenhand
I call this one MXPy (Methoxrolidine).
Can't wait for MXP2 (3-MeO-2'-Oxo-PCP).
I couldn't agree more.Not a good idea, giving methoxphenidine a short name "MXP" was a very bad choice if MXE was already assigned to methoxetamine, but it happened. MXP2 is just weird and not sensible at all in my opinion, we might as well call mephedrone "cocaine 2", I guess.
I think the convention to call derivatives as PCP, PCPy, PCE, etc. with functional groups preceding it is neat enough. Also, the apostrophe in front of substituents on the aromatic ring makes more sense to me, arylcyclohexanamines are derivatives of cyclohexanamine, so 3-methoxy is like a substituent on the substituent... But then again I doubt people are going to start writing 3'-MeO-PCP.
Seeing as people are saying that Methoxphenidine is MXP, I would like to that dangerous, harmful belief. MXP is not Methoxphenidine. MXx drugs are always arylcyclohexylamines. MXP is 3-MeO-2-OxO-PCP, a compound that has never been made. Anyone spreading the misinformation that MXP is the same thing as Methoxphenidine should be banned from this forum and any posts that say that should be deleted.
I don't fully understand naming conventions or how we come up with half this shit, so if you don't mind could you please elaborate for me why MXP exclusively represents 3-MeO-2-OxO-PCP, when the compound doesn't even exist (so you say)? Legitimate question mate, I might actually learn something here.
Well, pharmaceutical drug names are often made up and not derived from the IUPAC either.
Names are simply assigned by people. There are really no laws governing them, well, unless we're talking about registered pharmaceuticals or chemicals in general, that's different then. But in this case it's more of an agreement among people using these names, usually names are derived from full IUPAC or non-IUPAC names in some way. As MXP hadn't been earlier assigned to 3'-MeO-2-oxo-PCP by anyone, it was assigned by someone (I don't even know whether it was the original vendor or someone else) to methoxphenidine. As it caught on and is in use now, it doesn't make sense to reassign it to 3'-MeO-2-oxo-PCP because it will only generate unnecessary confusion. Certainly someone could have assigned it to 3'-MeO'-2-oxo first, but unless the compound had been described in a scientific paper, even in theory, or at least had already existed on the RC market, chances are it wouldn't have been noticed anyway.